# FDA Inspection 1261353 - Yabao Pharmaceutical Group Co., Ltd - January 24, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/yabao-pharmaceutical-group-co-ltd/cb7af93b-b23d-40e3-924d-9bd281e53dc0
Source feed: FDA_Inspections

> FDA Inspection 1261353 for Yabao Pharmaceutical Group Co., Ltd on January 24, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261353
- Company Name: Yabao Pharmaceutical Group Co., Ltd
- Inspection Date: 2025-01-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261353 - 2025-01-24](https://www.globalkeysolutions.net/records/fda_inspections/yabao-pharmaceutical-group-co-ltd/604a19d9-882a-477b-81fa-3b67e806f42f)
- [FDA Inspection 990175 - 2016-09-09](https://www.globalkeysolutions.net/records/fda_inspections/yabao-pharmaceutical-group-co-ltd/d5fd0312-1efe-496e-b6a8-0a8743de4c9c)

Company: https://www.globalkeysolutions.net/companies/yabao-pharmaceutical-group-co-ltd/3595b3c6-18cb-473b-ac11-ec2413262dfd

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c